Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2366-1089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?) ; day:13 ; month:1 ; year:2021 ; pages:1-12
Oncology and Therapy ; (13.1.2021), 1-12
- Urheber
-
Søreide, Kjetil
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40487-020-00136-y
- URN
-
urn:nbn:de:101:1-2021030714314069237141
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Søreide, Kjetil
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvant and neoadjuvant treatment of melanoma
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Adjuvant and neoadjuvant treatment of melanoma
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Adjuvant and neoadjuvant treatment of melanoma
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung